|
08:00 09:30 |
Oral Abstracts Session: Donation practices and public policy C1 |
400 |
|
08:00 09:30 |
Oral Abstracts Session: Kidney - Diagnostics 2 C2 |
401 |
|
08:00 09:30 |
Workshop Session: Expanding the donor pool C3 |
402 |
|
08:00 09:30 |
Workshop Session: Updates on post-transplant infections, prevention and optimization (all organs) C4 |
403 |
|
08:00 09:30 |
Oral Abstracts Session: Immune regulation and tolerance 2 C5 |
404 |
|
08:00 09:30 |
Workshop Session: Barriers to clinical application D |
405 |
|
08:00 09:30 |
Workshop Session: Prevention and management of donor-transmitted cancer after SOT E |
406 |
|
08:00 09:30 |
Oral Abstracts Session: Intestinal rehabilitation and transplant reports F |
407 |
|
09:40 11:40 |
President's plenary & awards A |
PL3 |
|
11:40 12:00 |
How do you identify and manage refractory CMV in solid organ transplant recipients? An interactive case-based discussion TTS Studio Organized by Takeda 
|
|
11:40 12:00 |
Coffee Break B |
|
12:00 13:00 |
Oral Abstracts Session: COVID-19 - Outcomes C1 |
410 |
|
12:00 13:00 |
Oral Abstracts Session: Basic and translational investigation/ combined liver-kidney transplantation C2 |
411 |
|
12:00 13:00 |
Mini-Oral Abstracts Session: Kidney - Outcomes 2 C3 |
412 |
|
12:00 13:00 |
Mini-Oral Abstracts Session: Organ tissue donation C4 |
413 |
|
12:00 13:00 |
Mini-Oral Abstracts Session: Xenotransplantation C5 |
414 |
|
12:00 13:00 |
Oral Abstracts Session: Ischemia/reperfusion injury 1 D |
415 |
|
12:00 13:00 |
Oral Abstracts Session: HLA-DSA E |
416 |
|
12:00 13:00 |
Mini-Oral Abstracts Session: Pediatric Transplantation F |
417 |
|
13:15 14:15 |
Industry Symposium: Evolving the Clinical Utility of dd-cfDNA (AlloSure/AlloSeq cfDNA) in Organ Transplantation A Organized by CareDx 
|
|
14:25 15:25 |
Oral Abstracts Session: COVID-19 - Transplant with positive donors, immunosuppression management C1 |
420 |
|
14:25 15:25 |
Oral Abstracts Session: Donor intend, identification, anesthesia and critical care C2 |
421 |
|
14:25 15:25 |
Mini-Oral Abstracts Session: Ischemia/reperfusion injury 2 C3 |
422 |
|
14:25 15:25 |
Mini-Oral Abstracts Session: Kidney - Living donation C4 |
423 |
|
14:25 15:25 |
Mini-Oral Abstracts Session: Transplant infectious diseases 2 C5 |
424 |
|
14:25 15:25 |
Oral Abstracts Session: Immunosuppression and cellular immunology D |
425 |
|
14:25 15:25 |
Oral Abstracts Session: Kidney - Metabolic challenges in transplantation E |
426 |
|
14:25 15:25 |
Mini-Oral Abstracts Session: Vascularized composite allografts and other topics F |
427 |
|
15:40 16:00 |
Mini-Oral Abstracts Session: Bone Marrow C3 |
429 |
|
16:00 17:30 |
State-of-the-Art Session: Hematopoietic stem cells transplantation, classical and new indications C3 |
432 |
|
16:00 17:30 |
State-of-the-Art Session: Vaccines & SOT: immunization saves lives C1 |
430 |
|
16:00 17:30 |
State-of-the-Art Session: Latest technologies and advances in the detection of allograft rejection and tissue injury status C2 |
431 |
|
16:00 17:30 |
State-of-the-Art Session: The impact of sex and gender in transplantation C4 |
433 |
|
16:00 17:30 |
State-of-the-Art Session: Stem cells and advanced organoid technology - Also VCA open discussion C5 |
434 |
|
16:00 17:30 |
State-of-the-Art Session: Multidisciplinary approach in transplant oncology - expanding liver transplantation for cancer: call in the multidisciplinary troops D |
435 |
|
16:00 17:30 |
State-of-the-Art Session: Surgical challenges in kidney transplant (adult and pediatric) E |
436 |
|
16:00 17:30 |
State-of-the-Art Session: COVID-19 era: what has changed for lung transplantation? F |
437 |
|
17:40 19:10 |
Future perspectives in transplantation A |
PL4 |
